A stent graft is a tube composed of fabric supported by a metal mesh called a stent. It is delivered using a catheter and is basically used for reinforcing a weak spot in the artery, called an aortic aneurysm. The ability of stent grafts to treat complex diseases such as juxtarenal and pararenal aneurysms, and iliac disease is a significant factor that propels market growth during the forecast period. This market is expected to post a steady market growth rate of more than 6% by 2019 owing to the growing incidence of aortic aneurysm among the aging population.
Increasing incidence of cardiac disorders is a significant factor that is expected to drive market growth during the forecast period. Due to unhealthy diet and physical inactivity, the number of people suffering from cardiac disorders is expected to increase. This recent increase in the incidence of cardiac disorders is expected to boost the demand for stent grafts during the forecast period.
Application-based segmentation of the stent grafts market
AAA stent grafts TAA stent grafts Technavio’s market research analyst has estimated the abdominal aortic aneurysm (AAA) stent grafts segment to account for more than 82% of the total market share by 2019. These stent grafts are useful in treating AAA and function by attaching itself to the aorta wall in a spring like fashion.
Geographical segmentation of the stent grafts market
APAC EMEA Americas In this market research report, analysts estimate the Americas to dominate the global market for stent grafts followed by the EMEA and the APAC regions. High incidence of aortic aneurysm in the US is responsible for this region’s high market dominion during the forecast period.
Competitive landscape and key vendors
This market is well organized and is highly competitive due to the presence of multiple vendors. The dominant vendors account for a major share of the market during the forecast period and face occasional competition from local manufacturers in various countries.
Key vendors in this market are-
Cook Medical C.R Bard Medtronic Other prominent vendors in this market include Aptus Endosystem, Bolton Medical, Cordis, GRIKIN Advanced Materials, LifeTech Scientific, Lombard Medical, St. George Medical, Terumo (Vascutek), TriVascular, WL Gore & Associates, Bolton Medical, Endologix, Johnson & Johnson, Jotec, Lombard Medical Technologies, Terumo, and TriVascular Technologies.
Key questions answered in the report include
What will the market size and the growth rate be in 2019? What are the key factors driving the global stent grafts market? What are the key market trends impacting the growth of the global stent grafts market? What are the challenges to market growth? Who are the key vendors in the global stent grafts market? What are the market opportunities and threats faced by the vendors in the global stent grafts market? Trending factors influencing the market shares of the EMEA, Americas, and APAC? What are the key outcomes of the five forces analysis of the global stent grafts market? Technavio also offers customization on reports based on specific client requirement.
Stent Grafts Market in China 2015-2019 Global Aortic Stent Grafts market 2014-2018
Technavio Announces the Publication of its Research Report – Global Stent Grafts Market 2015-2019
Technavio recognizes the following companies as the key players in the Global Stent Grafts Market: Cook Medical, C.R Bard and Medtronic
Other Prominent Vendors in the market are: Aptus Endosystem, Bolton Medical, Cordis, GRIKIN Advanced Materials, LifeTech Scientific, Lombard Medical, St. George Medical, Terumo (Vascutek), TriVascular, WL Gore & Associates, Bolton Medical, Endologix, Johnson & Johnson, Jotec, Lombard Medical Technologies, Terumo, and TriVascular Technologies.
Commenting on the report, an analyst from Technavio’s team said: “The global stent grafts market is expected to grow steadily during the forecast period, mainly because of some emerging trends. One such trend is the use of nanocomposite materials for stent grafts. These materials have enhanced the physical, mechanical, and chemical properties of stent grafts in various clinical studies. Another key trend is the increase in use of low-profile stent grafts for aneurysm repair.”
According to the report, increasing incidence of cardiac disorders and diseases such as obesity and diabetes among the aging population is one of the primary drivers boosting market growth. The increasing incidence of cardiac (aneurysm) diseases among the elderly population has led to an increase in the acceptance of EVAR procedures. Over 80% of deaths in men and women are related to cardiovascular disease, thereby contributing to the growth of the market.
Further, the report states that the risk of complications associated with EVAR/thoracic endovascular aneurysm repair (TEVAR) procedures, such as infections, leakage of blood around the graft, migration of the graft, and the blockage of blood flow through the graft, remain a major risk. Endoleak is one of the most serious complications and can be life-threatening. Another key challenge is the presence of an alternative therapy called balloon angioplasty.
Cook Medical, C.R Bard, Medtronic, Aptus Endosystem, Bolton Medical, Cordis, GRIKIN Advanced Materials, LifeTech Scientific, Lombard Medical, St. George Medical, Terumo (Vascutek), TriVascular, WL Gore & Associates, Bolton Medical, Endologix, Johnson & Johnson, Jotec, Lombard Medical Technologies, Terumo, and TriVascular Technologies.